HomeFileCoronary disease

Coronary disease

View Category

Antiplatelet

Post DES Dual Antiplatelet Therapy Still under Debate

The NIPPON trial (Nobori Dual Antiplatelet Therapy as Appropriate Duration) was a randomized study comparing a short dual...
solaci -
Learn More
Acute coronary syndromes

PCI Mortality and Volume in One Center: Associated?

The relationship between procedure volume and prognosis after a percutaneous coronary intervention remains unclear. Intuitively, we tend...
solaci -
Learn More
Chronic Ischemic cardiopathy

Glycemic control and risk of repeat revascularization

The association between glycemic control after coronary angioplasty and outcomes of the latter is controversial in many...
solaci -
Learn More
Chronic Ischemic cardiopathy

New generation DES present better results in vein grafts than older DES and BMS

There is little information comparing contemporary drug eluting stents (DES)  against bare metal stents (BMS), for PCI in...
solaci -
Learn More
Chronic Ischemic cardiopathy

BVS: Controvertial Scaffold

Courtesy of Dr. Agustín Vecchia. The advent of resorbable vascular scaffolds (BVS) generated high expectations among interventionists because...
solaci -
Learn More
Acute coronary syndromes

Prior assistance with Impella 2.5 lowers 30-day mortality in cardiogenic shock due to unprotected left main coronary artery lesion

Courtesy of Dr. Carlos Fava. The prevalence of cardiogenic shock in acute myocardial infarction (MI) is 7%-10%, and it is associated...
solaci -
Learn More
Chronic Ischemic cardiopathy

Less volume, more mortality: should we be concerned?

Courtesy of Dr. Agustín Vecchia. In general, guidelines recommend a number of procedures a year for operators to maintain...
solaci -
Learn More
Coronary disease

CTO in patients with acute myocardial infarction increases long term mortality

Courtesy of Dr. Carlos Fava. It has been proved that in a setting of acute myocardial infarction with multivessel...
solaci -
Learn More